Addressing Risks Associated with IV Push Medication Use in Adults

Experts will address the variability of practice with IV push medication use, including unnecessary unit-based preparation and dilution and unsafe injection practices, highlighting strategies necessary for the mitigation of risk.

Advancing Personalized Treatment of Patients with Hemophilia Through Comprehensive Pharmacokinetic Assessment

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Changing the Safety Paradigm on IV Medication Use: Recognizing the Risk and Taking Action

This activity will address the multi-factorial risks associated with IV medications, along with the need for proven safety technologies, practice innovation, and educational strategies to enhance safety in all phases of the medication use process.

Management and Trends in Pulmonary Arterial Hypertension

This activity will provide learners with foundational knowledge of PAH, including the role of several unique pathways.

MS-101: Pathogenesis, Diagnostic and Clinical Course Treatment Considerations in MS (A CSPE Core Curriculum Series)

This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.

MS-102: Navigating the MS Therapeutic Landscape (A CSPE Core Curriculum Series)

This activity provides an introduction to MS pathology, epidemiology, and symptom management to specialty pharmacists and nurses.

MS-103: The Role of the Specialty Pharmacy Professional in Managing MS Treatment: Care Transitions, Patient Education/Adherence, and Financial Considerations (A CSPE Core Curriculum Series)

As the third installment in the four-module NASP/CSPE MS Core Curriculum Series, this activity discusses the transitions of care, patient adherence strategies and financial considerations in the management of MS.

MS-104: Optimizing MS Treatment: Case Studies and Applications in Specialty Pharmacy Practice (A CSPE Core Curriculum Series)

As the final installment in the four-module NASP/CSPE MS Core Curriculum Series, this capstone activity of the MS curriculum uses case studies to allow participants to apply what was learned in modules MS-101 through MS-103.

Preventing Errors During Sterile Compounding: Taking the Next Steps

ISMP’s presentation will address the multi-factorial risks associated with intravenous medications and the need for adoption of proven technologies and best practices to optimize the safety and reliability of sterile compounding.

Product Quality Verification of Dietary Supplements

Patients have thousands of dietary supplement options available to them and many will ask for help in deciding. This activity is designed to support your counseling efforts by examining regulation with specific emphasis on the Dietary Supplement Health and Education Act (DSHEA), and more.

Pulmonary Arterial Hypertension: Individualized Treatment Strategies

This activity will provide pharmacists and nurses with an improved knowledge of PAH, including a review of pathophysiology, disease subcategories, diagnosis, treatment guidelines, approved therapies, disease progression, and disease monitoring recommendations.

Specialty Pharmacy Considerations in the Treatment of Pulmonary Arterial Hypertension

This activity will provide pharmacists and nurses education on developments within the PAH space and perspectives on the cost/benefit equation associated with therapies in the treatment of PAH.

Subcutaneous Insulin Use in Adults: Addressing Risks and Optimizing Safety

This activity will provide up-to-date information on the top insulin safety issues facing practitioners and an overview of ISMP’s newly-released national guidelines for safe subcutaneous insulin use.